These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1354876)

  • 41. Insights into the unusual alpha adrenoceptor subtype in dog saphenous vein using phenoxybenzamine.
    Low AM; Lu-Chao H; Loke JC; Kwan CY; Daniel EE
    J Pharmacol Exp Ther; 1999 Jan; 288(1):148-56. PubMed ID: 9862765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Norepinephrine-induced contractions of the rat aorta in the absence of extracellular calcium--I. Effects of alpha-adrenoreceptor blockers.
    Heaslip RJ; Rahwan RG
    Gen Pharmacol; 1983; 14(5):497-503. PubMed ID: 6139324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction between beta 2-adrenoceptor-mediated vasodilation and alpha 2-adrenoceptor-mediated vasoconstriction in the pithed normotensive rat.
    Wilffert B; Gouw MA; Timmermans PB; van Zwieten PA
    J Cardiovasc Pharmacol; 1983; 5(5):822-8. PubMed ID: 6195471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of vasoconstriction to cirazoline by calcium-entry blockade after phenoxybenzamine in rat perfused hindquarters.
    Korstanje C; van Zwieten PA
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Oct; 336(4):409-14. PubMed ID: 2893295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sensitivity of alpha-1 adrenoceptor-mediated pressor responses to inhibition by Ca++ entry blockers in the pithed rat: arguments against the role of receptor reserve.
    Timmermans PB; Beckeringh JJ; Van Zwieten PA; Thoolen MJ
    J Pharmacol Exp Ther; 1987 Mar; 240(3):864-70. PubMed ID: 3031277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of positive inotropy and metabolic coronary dilatation by myocardial alpha-adrenoceptors.
    Youngson BJ; Talesnik J
    Can J Physiol Pharmacol; 1985 Dec; 63(12):1513-21. PubMed ID: 3006894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional consequences of contrasting properties of alpha 1/alpha 2 systems.
    Timmermans PB; Thoolen MJ; De Jonge A; Wilffert B; Van Zwieten PA
    Clin Sci (Lond); 1985; 68 Suppl 10():93s-97s. PubMed ID: 2857626
    [No Abstract]   [Full Text] [Related]  

  • 48. Evidence for heterogeneity of prejunctional alpha-2-adrenoceptors.
    Oriowo MA; Hieble JP; Ruffolo RR
    Pharmacology; 1991; 43(1):1-13. PubMed ID: 1683709
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence against the role of alpha 1-adrenoceptor reserve in buffering the inhibitory effect of nifedipine on the contractility of canine vascular smooth muscle.
    Guan YY; Kwan CY; Daniel EE
    Can J Physiol Pharmacol; 1990 Oct; 68(10):1346-50. PubMed ID: 1964110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A tyrosine kinase regulates alpha-adrenoceptor-stimulated contraction and phospholipase D activation in the rat aorta.
    Jinsi A; Paradise J; Deth RC
    Eur J Pharmacol; 1996 Apr; 302(1-3):183-90. PubMed ID: 8791006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alpha-adrenergic vasoconstriction and receptor subtypes in large coronary arteries of calves.
    Young MA; Vatner DE; Knight DR; Graham RM; Homcy CJ; Vatner SF
    Am J Physiol; 1988 Dec; 255(6 Pt 2):H1452-9. PubMed ID: 2904772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of receptor reserve in the inhibition of alpha-1 adrenoceptor-mediated pressor responses by calcium antagonists in the pithed rat.
    Jim KF; Macia RA; Matthews WD
    J Pharmacol Exp Ther; 1986 Jul; 238(1):89-94. PubMed ID: 3014124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calcium influx-dependent and -independent alpha 1-adrenoceptor-mediated processes of vasoconstriction in vivo do not operate via different alpha 1-adrenoceptor subtypes.
    Korstanje C; Wilffert B; de Jonge A; Thoolen MJ; Timmermans PB; van Zwieten PA
    J Cardiovasc Pharmacol; 1984; 6(6):1102-8. PubMed ID: 6084766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interaction of vascular alpha-1 adrenoceptors with multiple signal transduction pathways.
    Ruffolo RR; Nichols AJ; Oriowo MA
    Blood Vessels; 1991; 28(1-3):122-8. PubMed ID: 1848121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of L-type calcium channel by tolazoline derivatives: role of isothiocyanate moiety.
    Lei L; Vaghy PL; Slavica M; De Los Angeles J; Smith B; Miller DD; Feller DR
    J Cardiovasc Pharmacol; 1998 May; 31(5):721-33. PubMed ID: 9593072
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Qualitative and quantitative differences between the postsynaptic alpha adrenoceptors of rabbit ear artery and thoracic aorta.
    Purdy RE; Ashbrook DW; Stupecky GL; Watanabe MY
    J Pharmacol Exp Ther; 1983 Mar; 224(3):543-51. PubMed ID: 6298403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence for and against heterogeneity of alpha 1-adrenoceptors.
    Hieble JP; DeMarinis RM; Matthews WD
    Life Sci; 1986 Apr; 38(15):1339-50. PubMed ID: 2870409
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tissue specific susceptibility of alpha-adrenoceptor mediated vasoconstriction to nifedipine.
    Müller-Schweinitzer E
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):64-9. PubMed ID: 6314155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence that cGMP is the mediator of endothelium-dependent inhibition of contractile responses of rat arteries to alpha-adrenoceptor stimulation.
    MacLeod KM; Ng DD; Harris KH; Diamond J
    Mol Pharmacol; 1987 Jul; 32(1):59-64. PubMed ID: 2885738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction between beta 2-adrenoceptor-mediated vasodilation and alpha 1-adrenoceptor-mediated vasoconstriction in the pithed normotensive rat.
    Wilffert B; Gouw MA; Timmermans PB; van Zwieten PA
    J Cardiovasc Pharmacol; 1983; 5(5):829-35. PubMed ID: 6195472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.